Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Quantitative comparison of blood vessel changes after treatment of retinopathy of prematurity with laser versus bevacizumab

Journal of American Association for Pediatric Ophthalmology and Strabismus(2022)10.1016/j.jaapos.2022.08.261Source: DataRank Database

Quantitative comparison of blood vessel changes after treatment of retinopathy of prematurity with laser versus bevacizumab is a research paper published in Journal of American Association for Pediatric Ophthalmology and Strabismus (2022). On theSindex it has a DataRank of 0.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access0 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 0.00)OA: greenTopics (39)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (6)

Gloria J. Hong ORCID,Sandra S. Stinnett ORCID,Sharon F. Freedman ORCID,David K. Wallace ORCID,S. Grace Prakalapakorn ORCID

Live enrichment

PubMed:36152755 OpenAlex:https://openalex.org/W4296640241

National Institutes of Health

Grant: K23EY024268

National Institutes of Health

Grant: UG1 EY011751

National Institutes of Health

Grant: 5UG1EY011751-29

Pediatric Eye Disease Investigator Group Coordinating Center

National Institutes of Health

Grant: 5K23EY024268-03

Evaluating a non-contact fundus camera for retinopathy of prematurity screening

FWCI

0.00

Citation Percentile

0.1%

greenLicense: Elsevier TDM

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/9772077

publisherhttps://api.elsevier.com/content/article/PII:S1091853122004414?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1091853122004414?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.jaapos.2022.08.261

Fields of Study

Retinopathy of Prematurity StudiesNeonatal Respiratory Health ResearchCardiovascular Conditions and Treatments03 medical and health sciences0302 clinical medicine

MeSH Terms

BevacizumabCombined Modality TherapyGestational AgeHumansInfant, NewbornLasersRetinopathy of PrematurityLaser CoagulationAngiogenesis InhibitorsVascular Endothelial Growth Factor AIntravitreal Injections

Keywords

BevacizumabRetinopathy of prematurityMedicineOphthalmologyLaser treatmentTortuosityTreatment modalityCardiologyLaserInternal medicineGestational ageChemotherapyVascular Endothelial Growth Factor Alaser photocoagulationLaser Coagulationbevacizumab injectionLasersInfant, NewbornAngiogenesis InhibitorsCombined Modality TherapyretinopathyIntravitreal InjectionsHumans

Sustainable Development Goals

SDG 0: Good health and well-being